Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial

标题
Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial
作者
关键词
Lipoprotein, GLP-1, Liraglutide, Low-grade inflammation
出版物
ATHEROSCLEROSIS
Volume 288, Issue -, Pages 60-66
出版商
Elsevier BV
发表日期
2019-07-06
DOI
10.1016/j.atherosclerosis.2019.07.007

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started